We are live on ! Find out more
IBER

Ibere Pharmaceuticals

Delisted

IBER was delisted on the 1st of March, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
GCL
1
Glazer Capital LLC
New York
$13.4M +$2.44M +243,601 +22%
MF
2
Magnetar Financial
Illinois
$7.93M
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$7.23M
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$6.85M
AC
5
Aristeia Capital
Connecticut
$6.81M +$2.5M +250,000 +59%
Millennium Management
6
Millennium Management
New York
$6.67M +$80K +8,000 +1%
FTCM
7
First Trust Capital Management
Illinois
$5.48M
Marshall Wace
8
Marshall Wace
United Kingdom
$5.45M
PC
9
Periscope Capital
Ontario, Canada
$4.75M +$142K +14,225 +3%
KL
10
KIM LLC
Kansas
$4.54M
LA
11
Linden Advisors
New York
$4.54M
SC
12
Sculptor Capital
New York
$4.29M
VI
13
Vestcor Inc
New Brunswick, Canada
$4.04M
SCM
14
Saba Capital Management
New York
$3.59M +$267K +26,700 +8%
CM
15
Cohanzick Management
New York
$3.48M -$31K -3,100 -0.9%
RCM
16
Radcliffe Capital Management
Pennsylvania
$3.3M
HSBC Holdings
17
HSBC Holdings
United Kingdom
$3.28M +$3.25M +325,108 New
Bank of America
18
Bank of America
North Carolina
$3.23M
Nomura Holdings
19
Nomura Holdings
Japan
$3.21M
MCM
20
Moore Capital Management
New York
$3.03M
CCA
21
Castle Creek Arbitrage
Colorado
$2.56M
WCMNY
22
Westchester Capital Management (New York)
New York
$2.46M +$2.44M +243,944 New
AA
23
AQR Arbitrage
Connecticut
$2.08M
PMAM
24
Picton Mahoney Asset Management
Ontario, Canada
$2.02M
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$1.51M -$1.25M -125,008 -45%